You are here: Home » Companies » Results
Business Standard

Ipca Labs second quarter net profit declines 6% to Rs 250 crore

The board declared an interim dividend of Rs 8 per share

IPCA Laboratories | Q2 results | Pharma sector

Press Trust of India  |  New Delhi 

drug, drugs, medicine, pills,
Photo: Shutterstock

Drug firm on Saturday reported a 6.30 per cent decline in its consolidated net profit to Rs 250.23 crore for the second quarter ended September 30.

The company had posted a net profit of Rs 267.07 crore for the corresponding period of the previous fiscal, said in a regulatory filing.

Consolidated revenue from operations stood at Rs 1,544.43 crore for the quarter under consideration. It was Rs 1,361.10 crore for the same period a year ago, it added.

The board has declared an interim dividend of Rs 8 per share, the filing said.

The board has "approved subdivision of every 1 equity share of the nominal/face value of Rs 2/ each into 2 equity shares of the nominal/face value of Re 1/- each, subject to the approval of the shareholders at the extraordinary general meeting scheduled to be held on December 16, 2021," it added.

The rationale behind the split is to improve the liquidity of the company's share and to make it more affordable for small investors so as to broad base the small investors base, it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, November 13 2021. 16:11 IST